ANI Pharma Inc (ANIP) 56.41 $ANIP Bio-Techne (TECH) Set

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 11:12 AM

ANI Pharma Inc (ANIP) 56.41 $ANIP

Bio-Techne (TECH) Set to Acquire Space Import-Export
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:37AM CDT
Bio-Techne Corporation (TECH) plans to acquire Space Import-Export, an Italy-based distribution company in the Life Sciences space, for an undisclosed sum.
FCSC: 1.24 (+0.04), ANIP: 56.41 (-0.10), CYTR: 2.30 (+0.04), TECH: 114.25 (-0.92)

Merck to Acquire Brazilian Animal Health Company for $400M
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:28AM CDT
Merck (MRK) announced that it will acquire the controlling interest in Vallee S.A., a Brazil-based privately held producer of animal health products.
GWPH: 97.41 (+2.58), ANIP: 56.41 (-0.10), UTHR: 109.92 (-1.24), MRK: 59.60 (+0.25)

Alnylam Stock Up on Favorable Patisiran and Revusiran Data
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:02AM CDT
Alnylam Pharmaceuticals' (ALNY) shares jumped 10.7% after the company reported new data from the ongoing studies on patisiran and revusiran.
ALNY: 63.44 (+1.26), INVA: 11.68 (+0.04), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11)

XBiotech Xilonix Positive in Phase III Colorectal Cancer Study
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 8:06AM CDT
XBiotech (XBIT) announced positive results from a phase III study on Xilonix for the treatment of advanced colorectal cancer.
XBIT: 19.17 (+3.39), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Integra LifeSciences at 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 7:32AM CDT
Integra Lifesciences (IART)has a market cap of $2.98 billion and a long-term expected earnings growth rate of 11.86%.
IART: 81.57 (+0.12), INVA: 11.68 (+0.04), FCSC: 1.24 (+0.04), ANIP: 56.41 (-0.10)

5 Top Biotech Performers of 2016
Afrasiab Mian - Zacks Investment Research - Fri Jul 01, 4:19PM CDT
2016 has been a busy year for the Biotech industry. Let's take a look 5 of the strongest year-to-date (YTD) performers.
XBIT: 19.17 (+3.39), ARGS: 6.39 (+0.15), OPXA: 4.43 (+0.17), ANIP: 56.41 (-0.10), RPRX: 1.75 (+0.02)

Arena (ARNA) to Cut 73% Workforce, Shifts Focus to Pipeline
Arpita Dutt - Zacks Investment Research - Fri Jul 01, 8:37AM CDT
Arena (ARNA) is looking to reduce costs through a 73% reduction in its workforce.
ANIP: 56.41 (-0.10), VVUS: 1.17 (-0.01), ARNA: 1.66 (-0.04)

Bristol-Myers, PsiOxus Strike Immuno-Oncology Collaboration
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:28AM CDT
Bristol-Myers (BMY) inked a clinical collaboration agreement with PsiOxus Therapeutics for the evaluation of a combination of Opdivo and enadenotucirev.
ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:11AM CDT
Horizon Pharma (HZNP) announced that it is looking to expand the approved age range for Ravicti for chronic management of urea cycle disorders in the U.S.
ANIP: 56.41 (-0.10), HZNP: 18.91 (+0.20), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:45AM CDT
Repligen Corporation (RGEN) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
RGEN: 28.13 (+0.38), ANIP: 56.41 (-0.10)

Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 10:09AM CDT
Esperion (ESPR) announced updates on a clinical development program as well as its regulatory plans for lead candidate, bempedoic acid (ETC-1002).
ESPR: 11.06 (-0.13), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Endo's Stock Gains on Vasostrict's New Patent Approval
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 9:38AM CDT
Endo International???s (ENDP) shares jumped 18.3% after the company announced that the U.S. Patent and Trademark Office has issued a new patent for Vasostrict.
ENDP: 17.43 (+0.01), ANIP: 56.41 (-0.10), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Two Small-Cap Healthcare Stocks That are Cheap Buys Right Now
Zacks Premium Research - Zacks Investment Research - Tue Jun 28, 11:09PM CDT
These small-cap stocks look like a bargain across fundamental valuation metrics. Their upside also has considerable potential.
PMC: 25.79 (+0.15), ANIP: 56.41 (-0.10)

The Medicines Co.'s Carbavance Scores in Phase III Study
Arpita Dutt - Zacks Investment Research - Tue Jun 28, 9:45AM CDT
The Medicines Co. (MDCO) intends to file for FDA approval in early 2017.
MDCO: 35.99 (+1.09), ANIP: 56.41 (-0.10), ARQL: 1.74 (unch), APRI: 0.38 (-0.01)

GW Pharmaceuticals Stock Up on Positive Epidiolex Data
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:33AM CDT
GW Pharmaceuticals (GWPH) announced positive data from the first phase III study on Epidiolex for the treatment of Lennox-Gastaut syndrome.
GWPH: 97.41 (+2.58), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Zacks.com featured highlights: John Bean Technologies, ANI Pharmaceuticals, Clearwater Paper, Companhia de Saneamento Basico do Estado de Sao Paulo and Unisys
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 8:30AM CDT
Zacks.com featured highlights: John Bean Technologies, ANI Pharmaceuticals, Clearwater Paper, Companhia de Saneamento Basico do Estado de Sao Paulo and Unisys
JBT: 63.32 (+0.69), CLW: 66.16 (+0.85), ANIP: 56.41 (-0.10), SBS: 9.04 (+0.13), UIS: 7.35 (+0.08)

Sanofi Inks Deal to Swap Business with Boehringer Ingelheim
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:15AM CDT
Sanofi (SNY) signed contracts with Boehringer Ingelheim for the strategic transaction initiated in Dec 2015 regarding an exchange of their businesses.
ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), RTRX: 18.51 (-0.14), SNY: 41.27 (+0.42)

XBiotech (XBIT) Catches Eye: Stock Adds 5.6% in Session
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:15AM CDT
XBiotech, Inc. (XBIT) shares rose almost 6% in the last trading session.
XBIT: 19.17 (+3.39), ANIP: 56.41 (-0.10)

Genmab/Novartis' Arzerra Gets Unfavorable CHMP Opinion
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 11:17AM CDT
Genmab (GNMSF) announced that CHMP issued a negative opinion for Arzerra as a maintenance therapy for relapsed chronic lymphatic leukemia.
JNJ: 122.99 (+0.14), ANIP: 56.41 (-0.10), NVS: 82.56 (+0.43)

Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:08AM CDT
Gilead Sciences' (GILD) once-daily single tablet regimen Odefsey gained EU approval for the treatment of HIV-1 infection in certain patients.
JNJ: 122.99 (+0.14), GILD: 87.13 (+0.58), ANIP: 56.41 (-0.10), RTRX: 18.51 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blokees Unveils 90+ New Wonders at Shanghai Fest

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Power Knot MEA Wins THE BIZZ 2026 for Excellence

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Monteverde Probes Four Key M&A Deals for Fairness

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Monster Energy Dominates Skateboard Podium at SLS Paris

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Black Culture Icon: Plastic-Covered Couch Takes Stage

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Lawsuit Highlights Inaction in School Bus Tragedy

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...